Kaempferol combined with epigallocatechin-3-gallate enhances bovine oocyte in vitro maturation by attenuating oxidative stress and improving mitochondrial function

This study investigated whether combined treatment with kaempferol and epigallocatechin-3-gallate (EGCG) offers superior protection during the in vitro maturation (IVM) and subsequent embryonic development of bovine oocytes compared to treatment with either agent alone. The underlying mechanisms were also examined. Preliminary dose–response assays revealed 0.1 µM kaempferol and 20 µM EGCG as the optimal concentrations when used individually. Accordingly, bovine cumulus–oocyte complexes were allocated to the following four groups: control, kaempferol only (0.1 µM), EGCG only (20 µM), and kaempferol + EGCG co-administration (0.05 µM + 10 µM, respectively). The combination treatment yielded the most favorable oocyte maturation and subsequent developmental outcomes. The first polar body extrusion rate was significantly higher in the combination group than in the control and EGCG groups ( P < 0.05), but did not differ significantly from the kaempferol-only group. In addition, cleavage and blastocyst formation rates were significantly higher in the combination group than in both single-treatment groups ( P < 0.05). Meanwhile, oocytes subjected to the combined treatment exhibited markedly lower intracellular reactive oxygen species levels and oocyte apoptosis rates, along with significantly higher glutathione levels, ATP production, and mitochondrial membrane potential than both individual treatment groups and the control ( P < 0.05). Molecular analyses further revealed synergistic effects in the co-administration group, which demonstrated the greater upregulation of SOD3 and SIRT2 (antioxidant defense), DNM1 and MFN2 (mitochondrial dynamics), and BCL2 (anti-apoptosis). Meanwhile, the pro-apoptotic gene BAX was downregulated in the combination treatment group ( P < 0.05). Overall, the results revealed that the combined administration of kaempferol and EGCG synergistically mitigates oxidative stress and preserves mitochondrial activity in bovine oocytes during IVM. This approach may therefore help in enhancing oocyte quality during livestock reproduction.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-03
DOI
https://doi.org/10.1038/s41598-026-79127-4
Primary Topic
Reproductive Biology and Fertility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Kaempferol combined with epigallocatechin-3-gallate enhances bovine oocyte in vitro maturation by attenuating oxidative stress and improving mitochondrial function

Yongxin Li, Hongtao Wang, Lichun Zhang, Hu Luan et al.
Scientific Reports
Reproductive Biology and Fertility
article

Kaempferol combined with epigallocatechin-3-gallate enhances bovine oocyte in vitro maturation by attenuating oxidative stress and improving mitochondrial function

Yongxin Li, Hongtao Wang, Lichun Zhang, Hu Luan, Weixia Wang, Xintao Li, Xiaoxin Chen, Yi Liu, Jianqiang Liu
article en

Abstract

This study investigated whether combined treatment with kaempferol and epigallocatechin-3-gallate (EGCG) offers superior protection during the in vitro maturation (IVM) and subsequent embryonic development of bovine oocytes compared to treatment with either agent alone. The underlying mechanisms were also examined. Preliminary dose–response assays revealed 0.1 µM kaempferol and 20 µM EGCG as the optimal concentrations when used individually. Accordingly, bovine cumulus–oocyte complexes were allocated to the following four groups: control, kaempferol only (0.1 µM), EGCG only (20 µM), and kaempferol + EGCG co-administration (0.05 µM + 10 µM, respectively). The combination treatment yielded the most favorable oocyte maturation and subsequent developmental outcomes. The first polar body extrusion rate was significantly higher in the combination group than in the control and EGCG groups ( P < 0.05), but did not differ significantly from the kaempferol-only group. In addition, cleavage and blastocyst formation rates were significantly higher in the combination group than in both single-treatment groups ( P < 0.05). Meanwhile, oocytes subjected to the combined treatment exhibited markedly lower intracellular reactive oxygen species levels and oocyte apoptosis rates, along with significantly higher glutathione levels, ATP production, and mitochondrial membrane potential than both individual treatment groups and the control ( P < 0.05). Molecular analyses further revealed synergistic effects in the co-administration group, which demonstrated the greater upregulation of SOD3 and SIRT2 (antioxidant defense), DNM1 and MFN2 (mitochondrial dynamics), and BCL2 (anti-apoptosis). Meanwhile, the pro-apoptotic gene BAX was downregulated in the combination treatment group ( P < 0.05). Overall, the results revealed that the combined administration of kaempferol and EGCG synergistically mitigates oxidative stress and preserves mitochondrial activity in bovine oocytes during IVM. This approach may therefore help in enhancing oocyte quality during livestock reproduction.

Scientific Reports
Jilin Academy of Agricultural Sciences (CN)
Openalex Percentile: Top 12%
Reproductive Biology and Fertility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon